Expression of deletion-containing dystrophins in mdx muscle: implications for gene therapy and dystrophin function.
The expression of full-length dystrophin and various dystrophin deletion mutants was monitored in mdx mouse muscle after intramuscular injection of dystrophin-encoding plasmid DNAs. Recombinant dystrophin proteins, including those lacking either the amino terminus, carboxyl terminus, or most of the central rod domain, showed localization to the plasma membrane. This suggests that there are multiple attachment sites for dystrophin to the plasma membrane. Only those constructs containing the carboxyl terminus were able to stabilize dystrophin-associated proteins (DAP) at the membrane, consistent with other studies that suggest that this domain is critical to DAP binding. Colocalization with DAP was not necessary for membrane localization of the various dystrophin molecules. However, stabilization and co-localization of the DAP did seem to be a prerequisite for expression and/or stabilization of mutant dystrophins beyond 1 wk and these same criteria seemed important for mitigating the histopathological consequences of dystrophin deficiency.
Fritz
J D
JD
Department of Pediatrics, Waisman Center, University of Wisconsin-Madison 53705, USA.
Danko
I
I
Roberds
S L
SL
Campbell
K P
KP
Latendresse
J S
JS
Wolff
J A
JA
D000818:Animals; D001483:Base Sequence; D016189:Dystrophin / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D017353:Gene Deletion; D015316:Genetic Therapy; D007273:Injections, Intramuscular; D051379:Mice; D018101:Mice, Inbred mdx; D008969:Molecular Sequence Data; D009137:Muscular Dystrophy, Animal / Q000235:genetics / Q000628:therapy*; D010957:Plasmids
D016189:Dystrophin